Bell Biosystems Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Employees
  • 12
  • Latest Deal Type
  • Out of Business

Bell Biosystems General Information


Developer of a cell therapeutic technology designed to create tools to accelerate the progress of innovations in oncology and cell therapy research. The company's technology delivers synthetic and artificial self-replicating contrast agents that enable therapeutic cells to be tracked in-vivo, enabling medical organizations to track, control and destroy transplanted cells.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 626 Bancroft Way
  • Suite A
  • Berkeley, CA 94710
  • United States
+1 (877) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bell Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 01-Jun-2019 00.000 Completed Out of Business
11. Accelerator/Incubator 00.000 Completed Generating Revenue
10. Later Stage VC 15-Aug-2018 00.000 Completed Generating Revenue
9. Grant 07-Sep-2016 00.00 00.000 Completed Generating Revenue
8. Later Stage VC (Series A) 13-Apr-2015 00000 00.000 0000 Completed Startup
7. Early Stage VC (Series A) 11-Jun-2014 000 00.000 000.00 Completed Startup
6. Accelerator/Incubator 12-Mar-2014 00000 Completed Startup
5. Grant 01-Jul-2012 00000 00000 Completed Startup
4. Early Stage VC 30-May-2012 $370K $390K Completed Startup
3. Accelerator/Incubator $20K Completed Startup
To view Bell Biosystems’s complete valuation and funding history, request access »

Bell Biosystems Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Bell Biosystems’s complete cap table history, request access »

Bell Biosystems Board Members (7)

Name Representing Role Since
Christian Olgaard Ph.D Self Board Member 000 0000
Gil Van Bokkelen Ph.D Self Board Member 000 0000
Stuart Berman Self Board Member 000 0000
Una Ryan Ph.D Self Board Member 000 0000
Winnie Wan Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Bell Biosystems Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial